Abu Dhabi, UAE, February 20, 2025: Burjeel Holdings PLC, a leading super-specialty healthcare provider in the MENA region, has announced that its Board of Directors has authorized the management to explore a share buyback program of up to 10% of the Group’s share capital. This initiative, subject to regulatory and shareholder approval, reflects the Board’s confidence in Burjeel’s significant growth potential.The buyback program aligns with Burjeel Holdings’ commitment to optimizing capital structure and enhancing shareholder value. The Group is on track for mid-teens revenue growth and EBITDA margin expansion in 2025 and beyond, driven by the accelerated ramp-up of high-growth assets, expansion of high-complexity procedures, and ongoing cost optimization initiatives.Upon approval, the buyback will be funded through the Group’s operating cash flow, highlighting its strong financial position. The Group’s CEO, Mr. John Sunil, emphasized that the buyback initiative reflects the intrinsic value of the company, which is not yet fully reflected in its market valuation.Stay tuned for further updates as Burjeel Holdings works with regulators and shareholders to finalize the program.I hope you find this summary helpful! If you need more information or have any other requests, feel free to ask.
